NovaBridge Biosciences (NBP) Depreciation & Amortization (CF) (2019 - 2025)
NovaBridge Biosciences (NBP) posted quarterly Depreciation & Amortization (CF) of $15000.0 for Q4 2025, down 31.82% year-on-year from $22000.0 in Q4 2024, and down 11.76% on a QoQ basis from $17000.0 in Q3 2025.
NovaBridge Biosciences (NBP) Depreciation & Amortization (CF) (2019 - 2025) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Depreciation & Amortization (CF) for 4 consecutive years, with $15000.0 the latest figure, recorded in Q4 2025.
- Quarterly Depreciation & Amortization (CF) fell 31.82% year-over-year to $15000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $32000.0 (down 23.81% YoY) and the FY2025 annual result came in at $68000.0, down 77.33% from the prior year.
- Depreciation & Amortization (CF) fell to $15000.0 in Q4 2025 per NBP's latest filing, from $17000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for NBP reached as high as $22000.0 in Q4 2024 and fell as low as $15000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | NovaBridge Biosciences | 389.86 Mn | 389.86 Mn | - | 15,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15,000.00 |
| Dec 31, 2025 | 15,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Sep 30, 2025 | 17,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Dec 31, 2024 | 22,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Sep 30, 2024 | 20,000.00 |
| Dec 31, 2020 | 755,220.95 |
| Dec 31, 2020 | 755,220.95 |
| Sep 30, 2020 | 382,291.49 |
| Sep 30, 2020 | 382,291.49 |
| Dec 31, 2019 | 425,074.79 |
| Dec 31, 2019 | 425,074.79 |